Helicobacter Pylori Non-Invasive Testing Market

Helicobacter Pylori Non-Invasive Testing Market Analysis – Size, Share, and Forecast 2023 to 2033

The global helicobacter pylori non-invasive testing market is projected to register at a moderate-paced CAGR of 4.4% over the forecast period. The helicobacter pylori non-invasive testing market is currently valued at USD 650.50 Million in 2023. By 2033, demand for helicobacter pylori non-invasive testing is expected to reach a high of USD 1000.57 Million.

This growth in the adoption of helicobacter pylori non-invasive testing is supported by the following:

• Non-invasive testing has become increasingly popular for identifying H. pylori infections.
• The dearth of endoscopic resources
• Infection awareness among governments is growing, which is important for getting a proper diagnosis.
• A dramatic increase in the need for point-of-care testing devices
• The accessibility of diagnostic tools.

Key Success Factors Driving the Helicobacter Pylori Non-Invasive Testing Industry

Immunoassays are biochemical tests that determine how much of an analyte is present. It doesn't matter what size the analyte is; it might be a huge protein, an antibody the body has created in response to an illness or a little molecule. The accuracy and reliability of immunoassays are unparalleled. They are very specific since antibodies and purified antigens are used as reagents. Diseases can be diagnosed more precisely using this assay since it measures antigen presence. It is a highly selective bioanalytical approach that uses an antibody or antigen as a biorecognition agent to quantify the presence or quantity of analytes ranging from tiny molecules to macromolecules in solution.

Due to the presence of several advanced technologies, such as the enzyme immunoassays, which are used for the detection of antibodies, the immunoassay segment currently holds a significant market share in the helicobacter pylori non-invasive testing market and is expected to show a similar trend over the forecast period. Key factors propelling the immunoassay market are the growing incidence of gastritis and infections caused by Helicobacter pylori, as well as technical developments.

For instance, in 2021, the worldwide prevalence of gastritis was estimated to be between 50.0% and 56.0%, according to a study titled "Diagnosis of Helicobacter pylori Infection and Recent Advances," with the prevalence of chronic atrophic gastritis falling within that range between 20% and 30%. Helicobacter pylori infection was shown to be proportional to gastritis prevalence, and cases of Helicobacter pylori-positive gastritis were found to account for more than 80.0% of all cases. Since such illnesses are typically detected by immunoassays, rising instances of Helicobacter pylori infection and gastritis are expected to drive the segment growth throughout the forecast period.

Attributes	Details
Market Value (2023)	USD 650.50 Million
Market Value (2033)	USD 1000.57 Million
CAGR (2023 to 2033)	4.4%

Major Trends, Drivers, and Challenges Impacting the Helicobacter Pylori Non-Invasive Testing Market

Increased Patient Requirement for POC Increases the Demand for H. pylori Tests Drives the Development of the Industry as a Whole

The National Institutes of Health (NIH) research states that IgG serology, the C-Urea Breath Test (UBT), and the monoclonal stool antigen test are all non-invasive, Point-of-care (POC) diagnostic options for primary care settings that can detect H. pylori. UBT is the only one of these that reliably verifies whether an infection is present or has been eradicated. According to the research published in Gut and Liver, UBT is an accurate, non-invasive option that is safe for use on both children and pregnant women.

In addition, H. pylori laboratory test results can now be obtained in a shorter amount of time owing to Point-of-care Testing (POCT), a tried-and-true method. Popularity, the number of people getting tested, and the variety of therapeutic uses for POCTs have all increased as leading companies keep releasing new models. In addition, Point-of-care Testing (POCT) is now widely used in all hospitals and is increasingly being adopted as the norm in other types of healthcare facilities. The global helicobacter pylori non-invasive testing market is expected to expand because of the aforementioned factors throughout the forecast period. This means that the increasing number of H. pylori sufferers is a key factor propelling the helicobacter pylori non-invasive testing market forward.

The industry's growth may be hampered by a lack of educated doctors to perform intrusive tests.

To accurately diagnose Helicobacter pylori infection and determine the best course of therapy, a surgeon or medical professional must perform an invasive procedure that often includes a biopsy and endoscopy. Market growth could be stymied, however, if countries with fewer healthcare resources and a corresponding shortage of trained professionals saw a decline in the number of people getting their diseases checked out. Unfortunately, many nations with low or middle income lack the hospital and medical training infrastructure necessary to produce highly qualified physicians. However, there are additional difficulties for doctors when treating Helicobacter pylori, as no first-line therapy is effective for everyone.

The helicobacter pylori non-invasive testing market is expected to expand at a modest rate worldwide. Although testing has become more common, diagnosis has been hindered by the fact that HIV infection often has no outward symptoms. This is a major factor in the market's slow expansion. It is also expected that h. pylori non-invasive testing is expected to decrease as attention is redirected to ending the current coronavirus pandemic.

Helicobacter Pylori Non-Invasive Testing Industry Analysis by Type, Method, and End Use

From 2023 to 2033, the clinic market is expected to grow at a CAGR of over 6%, as more people choose clinics over hospitals because of their lower costs and higher quality of care. The reason for this is that people are more likely to seek help from clinics since they offer high-quality care and respond quickly to patient needs, resulting in effective treatment at an affordable price. The premium services provided by clinics as a result of efficient disease management tactics are also expected to fuel market growth.

Due to its non-invasive nature and its ability to offer speedy findings, the POC testing segment accounted for more than 35% of the business. This is due, in large part, to rising Research and Development spending and joint research activities amongst industry heavyweights that are fostering innovation and new product development.

The helicobacter pylori non-invasive testing market may be broken down into two distinct subsegments: invasive helicobacter pylori tests and non-invasive helicobacter pylori tests. Since quick urease tests are both effective and inexpensive, this market subsegment is expected to grow at a CAGR of 6.5% between 2023 and 2032. Patients who do not respond well to antibiotic medication, who have symptoms of severe gastrointestinal issues, and who require gastric endoscopy have a significant demand for invasive diagnostic methods.

Top Regions Deploying Helicobacter Pylori Non-Invasive Testing Solutions

How is the USA Helicobacter Pylori Non-Invasive Testing Market Developing?

Globally, North America accounts for the largest helicobacter pylori non-invasive testing market. The expansion of healthcare infrastructure in addition to the rising incidence of stomach cancer, duodenal ulcers, and gastric ulcers in North America are driving forces behind the helicobacter pylori non-invasive testing market's expansion.

The NIH found that 5 percent of USA youngsters under the age of 10 have H. pylori in their systems. In addition, 30% to 40% of Americans have H. pylori infection, according to research from the USA Department of Health and Human Services. Furthermore, socioeconomic variables such as poor income, less education, home crowding, and immigration all contribute to a higher prevalence of H. pylori infection in the USA's Hispanic and Black populations. In order to treat H. pylori, the FDA recommends either Proton Pump Inhibitors (PPI) and two antibiotics or bismuth subsalicylate, acid suppressors, and two antibiotics, as detailed in a paper available from the ClinMed International Library.

There is resistance to effectiveness with the currently available first-line medication regimens. Due to resistance in H. pylori to common antibiotics, the USA, for example, observed 75% eradication rates utilizing these regimens. The largest rates of resistance are shown with Clarithromycin and Metronidazole and characteristics related to resistance include race, age, location, and the presence or absence of ulcer disease.

What are the driving factors for the Chinese Helicobacter Pylori Non-Invasive Testing Market?

The market for non-invasive testing for Helicobacter Pylori (H. pylori) in Asia and the Pacific is dominated by China. When it comes to healthcare and pharmaceuticals, China is a developing powerhouse in the Asia-Pacific region. Many international manufacturers of medical, pharmaceutical, and biotechnology products are based in China. High rates of H. pylori infection and gastric (stomach) cancer cases have spurred the development of diagnostic testing kits and technologies for H. pylori detection by pharmaceutical and biotechnology firms.

What are the defining characteristics of the Japanese Helicobacter Pylori Non-Invasive Testing Market?

The Japanese medical industry is among the world's most advanced markets. Due to widespread infection with H. pylori and a penchant for consuming smoked and salted foods, Roswell Park Comprehensive Cancer Center reports that Japan has an alarmingly high incidence of stomach cancer. In Japan, 50,000 individuals each year are killed by stomach cancer, making it the third deadliest form of the disease. In addition, 98% of gastric cancer in Japan can be attributed to H. pylori, according to a study published in 2020 by Wiley Online Library.

Recent investigations have indicated that H. pylori infection is the primary cause of stomach cancer, while it is one of many factors. The expansion of the helicobacter pylori non-invasive testing market in Japan is anticipated to benefit from the aforementioned factors over the forecast period.

Leading Suppliers of Helicobacter Pylori Non-Invasive Testing Kits

Companies like DiaSorin S.p.A., Meridian Bioscience, Inc., Exalenz Bioscience Ltd., Alere, Thermo Fisher Scientific, Biomerica, Inc., Certest Biotec S.L., Sekisui Diagnostics, CorisBioconcept SPRL, and Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd. are all major players in the global helicobacter pylori market. These leaders are anticipated to retain their positions of prominence during the prediction horizon.

Some recent developments in the helicobacter pylori non-invasive testing market include:

Meridian Bioscience, Inc. announced in March 2020 that its novel Curian and Curian HpSA assay had been approved by the Food and Drug Administration. They hope that their efforts to preserve their position as the industry leader in testing for gastrointestinal diseases would be aided by the introduction of this analyzer and its initial assay.

Thermo Fischer Scientific announced in December 2021 that it would be purchasing PPD, Inc. for USD17.4 billion. PPD is a top global provider of clinical research services to the biopharma & biotech industry.

Table of Content

• 1. Executive Summary
• 2. Market Overview
• 3. Market Background
• 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
• 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Test Type
  • 5.1. Serology Test
  • 5.2. Stool Antigen Test (SAT)
  • 5.3. Urea Breath Test (UBT)
• 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Test Method
  • 6.1. Laboratory-based Tests
  • 6.2. Point-of-Care Tests
• 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-user
  • 7.1. Hospitals
  • 7.2. Clinics
  • 7.3. Diagnostic Laboratories
• 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
  • 8.1. North America
  • 8.2. Latin America
  • 8.3. Europe
  • 8.4. South Asia
  • 8.5. East Asia
  • 8.6. Oceania
  • 8.7. Middle East and Africa (MEA)
• 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
• 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
• 11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
• 12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
• 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
• 14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
• 15. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
• 16. Key Countries Market Analysis
• 17. Market Structure Analysis
• 18. Competition Analysis
  • 18.1. DiaSorin S.p.A.
  • 18.2. Meridian Bioscience, Inc.
  • 18.3. Exalenz Bioscience Ltd.
  • 18.4. Alere
  • 18.5. Thermo Fisher Scientific
  • 18.6. Biomerica, Inc.
  • 18.7. Certest Biotec S.L.
  • 18.8. Sekisui Diagnostics
  • 18.9. Coris Bioconcept SPRL
  • 18.10. Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd
• 19. Assumptions & Acronyms Used
• 20. Research Methodology

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2017 to 2032

Table 2: Global Market Value (US$ Million) Forecast by Test Type, 2017 to 2032

Table 3: Global Market Value (US$ Million) Forecast by Test Method, 2017 to 2032

Table 4: Global Market Value (US$ Million) Forecast by End-user, 2017 to 2032

Table 5: North America Market Value (US$ Million) Forecast by Country, 2017 to 2032

Table 6: North America Market Value (US$ Million) Forecast by Test Type, 2017 to 2032

Table 7: North America Market Value (US$ Million) Forecast by Test Method, 2017 to 2032

Table 8: North America Market Value (US$ Million) Forecast by End-user, 2017 to 2032

Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2017 to 2032

Table 10: Latin America Market Value (US$ Million) Forecast by Test Type, 2017 to 2032

Table 11: Latin America Market Value (US$ Million) Forecast by Test Method, 2017 to 2032

Table 12: Latin America Market Value (US$ Million) Forecast by End-user, 2017 to 2032

Table 13: Europe Market Value (US$ Million) Forecast by Country, 2017 to 2032

Table 14: Europe Market Value (US$ Million) Forecast by Test Type, 2017 to 2032

Table 15: Europe Market Value (US$ Million) Forecast by Test Method, 2017 to 2032

Table 16: Europe Market Value (US$ Million) Forecast by End-user, 2017 to 2032

Table 17: South Asia Market Value (US$ Million) Forecast by Country, 2017 to 2032

Table 18: South Asia Market Value (US$ Million) Forecast by Test Type, 2017 to 2032

Table 19: South Asia Market Value (US$ Million) Forecast by Test Method, 2017 to 2032

Table 20: South Asia Market Value (US$ Million) Forecast by End-user, 2017 to 2032

Table 21: East Asia Market Value (US$ Million) Forecast by Country, 2017 to 2032

Table 22: East Asia Market Value (US$ Million) Forecast by Test Type, 2017 to 2032

Table 23: East Asia Market Value (US$ Million) Forecast by Test Method, 2017 to 2032

Table 24: East Asia Market Value (US$ Million) Forecast by End-user, 2017 to 2032

Table 25: Oceania Market Value (US$ Million) Forecast by Country, 2017 to 2032

Table 26: Oceania Market Value (US$ Million) Forecast by Test Type, 2017 to 2032

Table 27: Oceania Market Value (US$ Million) Forecast by Test Method, 2017 to 2032

Table 28: Oceania Market Value (US$ Million) Forecast by End-user, 2017 to 2032

Table 29: MEA Market Value (US$ Million) Forecast by Country, 2017 to 2032

Table 30: MEA Market Value (US$ Million) Forecast by Test Type, 2017 to 2032

Table 31: MEA Market Value (US$ Million) Forecast by Test Method, 2017 to 2032

Table 32: MEA Market Value (US$ Million) Forecast by End-user, 2017 to 2032

List of Figures

Figure 1: Global Market Value (US$ Million) by Test Type, 2022 to 2032

Figure 2: Global Market Value (US$ Million) by Test Method, 2022 to 2032

Figure 3: Global Market Value (US$ Million) by End-user, 2022 to 2032

Figure 4: Global Market Value (US$ Million) by Region, 2022 to 2032

Figure 5: Global Market Value (US$ Million) Analysis by Region, 2017 to 2032

Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2022 to 2032

Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2022 to 2032

Figure 8: Global Market Value (US$ Million) Analysis by Test Type, 2017 to 2032

Figure 9: Global Market Value Share (%) and BPS Analysis by Test Type, 2022 to 2032

Figure 10: Global Market Y-o-Y Growth (%) Projections by Test Type, 2022 to 2032

Figure 11: Global Market Value (US$ Million) Analysis by Test Method, 2017 to 2032

Figure 12: Global Market Value Share (%) and BPS Analysis by Test Method, 2022 to 2032

Figure 13: Global Market Y-o-Y Growth (%) Projections by Test Method, 2022 to 2032

Figure 14: Global Market Value (US$ Million) Analysis by End-user, 2017 to 2032

Figure 15: Global Market Value Share (%) and BPS Analysis by End-user, 2022 to 2032

Figure 16: Global Market Y-o-Y Growth (%) Projections by End-user, 2022 to 2032

Figure 17: Global Market Attractiveness by Test Type, 2022 to 2032

Figure 18: Global Market Attractiveness by Test Method, 2022 to 2032

Figure 19: Global Market Attractiveness by End-user, 2022 to 2032

Figure 20: Global Market Attractiveness by Region, 2022 to 2032

Figure 21: North America Market Value (US$ Million) by Test Type, 2022 to 2032

Figure 22: North America Market Value (US$ Million) by Test Method, 2022 to 2032

Figure 23: North America Market Value (US$ Million) by End-user, 2022 to 2032

Figure 24: North America Market Value (US$ Million) by Country, 2022 to 2032

Figure 25: North America Market Value (US$ Million) Analysis by Country, 2017 to 2032

Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 28: North America Market Value (US$ Million) Analysis by Test Type, 2017 to 2032

Figure 29: North America Market Value Share (%) and BPS Analysis by Test Type, 2022 to 2032

Figure 30: North America Market Y-o-Y Growth (%) Projections by Test Type, 2022 to 2032

Figure 31: North America Market Value (US$ Million) Analysis by Test Method, 2017 to 2032

Figure 32: North America Market Value Share (%) and BPS Analysis by Test Method, 2022 to 2032

Figure 33: North America Market Y-o-Y Growth (%) Projections by Test Method, 2022 to 2032

Figure 34: North America Market Value (US$ Million) Analysis by End-user, 2017 to 2032

Figure 35: North America Market Value Share (%) and BPS Analysis by End-user, 2022 to 2032

Figure 36: North America Market Y-o-Y Growth (%) Projections by End-user, 2022 to 2032

Figure 37: North America Market Attractiveness by Test Type, 2022 to 2032

Figure 38: North America Market Attractiveness by Test Method, 2022 to 2032

Figure 39: North America Market Attractiveness by End-user, 2022 to 2032

Figure 40: North America Market Attractiveness by Country, 2022 to 2032

Figure 41: Latin America Market Value (US$ Million) by Test Type, 2022 to 2032

Figure 42: Latin America Market Value (US$ Million) by Test Method, 2022 to 2032

Figure 43: Latin America Market Value (US$ Million) by End-user, 2022 to 2032

Figure 44: Latin America Market Value (US$ Million) by Country, 2022 to 2032

Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2017 to 2032

Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 48: Latin America Market Value (US$ Million) Analysis by Test Type, 2017 to 2032

Figure 49: Latin America Market Value Share (%) and BPS Analysis by Test Type, 2022 to 2032

Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Test Type, 2022 to 2032

Figure 51: Latin America Market Value (US$ Million) Analysis by Test Method, 2017 to 2032

Figure 52: Latin America Market Value Share (%) and BPS Analysis by Test Method, 2022 to 2032

Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Test Method, 2022 to 2032

Figure 54: Latin America Market Value (US$ Million) Analysis by End-user, 2017 to 2032

Figure 55: Latin America Market Value Share (%) and BPS Analysis by End-user, 2022 to 2032

Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End-user, 2022 to 2032

Figure 57: Latin America Market Attractiveness by Test Type, 2022 to 2032

Figure 58: Latin America Market Attractiveness by Test Method, 2022 to 2032

Figure 59: Latin America Market Attractiveness by End-user, 2022 to 2032

Figure 60: Latin America Market Attractiveness by Country, 2022 to 2032

Figure 61: Europe Market Value (US$ Million) by Test Type, 2022 to 2032

Figure 62: Europe Market Value (US$ Million) by Test Method, 2022 to 2032

Figure 63: Europe Market Value (US$ Million) by End-user, 2022 to 2032

Figure 64: Europe Market Value (US$ Million) by Country, 2022 to 2032

Figure 65: Europe Market Value (US$ Million) Analysis by Country, 2017 to 2032

Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 68: Europe Market Value (US$ Million) Analysis by Test Type, 2017 to 2032

Figure 69: Europe Market Value Share (%) and BPS Analysis by Test Type, 2022 to 2032

Figure 70: Europe Market Y-o-Y Growth (%) Projections by Test Type, 2022 to 2032

Figure 71: Europe Market Value (US$ Million) Analysis by Test Method, 2017 to 2032

Figure 72: Europe Market Value Share (%) and BPS Analysis by Test Method, 2022 to 2032

Figure 73: Europe Market Y-o-Y Growth (%) Projections by Test Method, 2022 to 2032

Figure 74: Europe Market Value (US$ Million) Analysis by End-user, 2017 to 2032

Figure 75: Europe Market Value Share (%) and BPS Analysis by End-user, 2022 to 2032

Figure 76: Europe Market Y-o-Y Growth (%) Projections by End-user, 2022 to 2032

Figure 77: Europe Market Attractiveness by Test Type, 2022 to 2032

Figure 78: Europe Market Attractiveness by Test Method, 2022 to 2032

Figure 79: Europe Market Attractiveness by End-user, 2022 to 2032

Figure 80: Europe Market Attractiveness by Country, 2022 to 2032

Figure 81: South Asia Market Value (US$ Million) by Test Type, 2022 to 2032

Figure 82: South Asia Market Value (US$ Million) by Test Method, 2022 to 2032

Figure 83: South Asia Market Value (US$ Million) by End-user, 2022 to 2032

Figure 84: South Asia Market Value (US$ Million) by Country, 2022 to 2032

Figure 85: South Asia Market Value (US$ Million) Analysis by Country, 2017 to 2032

Figure 86: South Asia Market Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 87: South Asia Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 88: South Asia Market Value (US$ Million) Analysis by Test Type, 2017 to 2032

Figure 89: South Asia Market Value Share (%) and BPS Analysis by Test Type, 2022 to 2032

Figure 90: South Asia Market Y-o-Y Growth (%) Projections by Test Type, 2022 to 2032

Figure 91: South Asia Market Value (US$ Million) Analysis by Test Method, 2017 to 2032

Figure 92: South Asia Market Value Share (%) and BPS Analysis by Test Method, 2022 to 2032

Figure 93: South Asia Market Y-o-Y Growth (%) Projections by Test Method, 2022 to 2032

Figure 94: South Asia Market Value (US$ Million) Analysis by End-user, 2017 to 2032

Figure 95: South Asia Market Value Share (%) and BPS Analysis by End-user, 2022 to 2032

Figure 96: South Asia Market Y-o-Y Growth (%) Projections by End-user, 2022 to 2032

Figure 97: South Asia Market Attractiveness by Test Type, 2022 to 2032

Figure 98: South Asia Market Attractiveness by Test Method, 2022 to 2032

Figure 99: South Asia Market Attractiveness by End-user, 2022 to 2032

Figure 100: South Asia Market Attractiveness by Country, 2022 to 2032

Figure 101: East Asia Market Value (US$ Million) by Test Type, 2022 to 2032

Figure 102: East Asia Market Value (US$ Million) by Test Method, 2022 to 2032

Figure 103: East Asia Market Value (US$ Million) by End-user, 2022 to 2032

Figure 104: East Asia Market Value (US$ Million) by Country, 2022 to 2032

Figure 105: East Asia Market Value (US$ Million) Analysis by Country, 2017 to 2032

Figure 106: East Asia Market Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 107: East Asia Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 108: East Asia Market Value (US$ Million) Analysis by Test Type, 2017 to 2032

Figure 109: East Asia Market Value Share (%) and BPS Analysis by Test Type, 2022 to 2032

Figure 110: East Asia Market Y-o-Y Growth (%) Projections by Test Type, 2022 to 2032

Figure 111: East Asia Market Value (US$ Million) Analysis by Test Method, 2017 to 2032

Figure 112: East Asia Market Value Share (%) and BPS Analysis by Test Method, 2022 to 2032

Figure 113: East Asia Market Y-o-Y Growth (%) Projections by Test Method, 2022 to 2032

Figure 114: East Asia Market Value (US$ Million) Analysis by End-user, 2017 to 2032

Figure 115: East Asia Market Value Share (%) and BPS Analysis by End-user, 2022 to 2032

Figure 116: East Asia Market Y-o-Y Growth (%) Projections by End-user, 2022 to 2032

Figure 117: East Asia Market Attractiveness by Test Type, 2022 to 2032

Figure 118: East Asia Market Attractiveness by Test Method, 2022 to 2032

Figure 119: East Asia Market Attractiveness by End-user, 2022 to 2032

Figure 120: East Asia Market Attractiveness by Country, 2022 to 2032

Figure 121: Oceania Market Value (US$ Million) by Test Type, 2022 to 2032

Figure 122: Oceania Market Value (US$ Million) by Test Method, 2022 to 2032

Figure 123: Oceania Market Value (US$ Million) by End-user, 2022 to 2032

Figure 124: Oceania Market Value (US$ Million) by Country, 2022 to 2032

Figure 125: Oceania Market Value (US$ Million) Analysis by Country, 2017 to 2032

Figure 126: Oceania Market Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 127: Oceania Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 128: Oceania Market Value (US$ Million) Analysis by Test Type, 2017 to 2032

Figure 129: Oceania Market Value Share (%) and BPS Analysis by Test Type, 2022 to 2032

Figure 130: Oceania Market Y-o-Y Growth (%) Projections by Test Type, 2022 to 2032

Figure 131: Oceania Market Value (US$ Million) Analysis by Test Method, 2017 to 2032

Figure 132: Oceania Market Value Share (%) and BPS Analysis by Test Method, 2022 to 2032

Figure 133: Oceania Market Y-o-Y Growth (%) Projections by Test Method, 2022 to 2032

Figure 134: Oceania Market Value (US$ Million) Analysis by End-user, 2017 to 2032

Figure 135: Oceania Market Value Share (%) and BPS Analysis by End-user, 2022 to 2032

Figure 136: Oceania Market Y-o-Y Growth (%) Projections by End-user, 2022 to 2032

Figure 137: Oceania Market Attractiveness by Test Type, 2022 to 2032

Figure 138: Oceania Market Attractiveness by Test Method, 2022 to 2032

Figure 139: Oceania Market Attractiveness by End-user, 2022 to 2032

Figure 140: Oceania Market Attractiveness by Country, 2022 to 2032

Figure 141: MEA Market Value (US$ Million) by Test Type, 2022 to 2032

Figure 142: MEA Market Value (US$ Million) by Test Method, 2022 to 2032

Figure 143: MEA Market Value (US$ Million) by End-user, 2022 to 2032

Figure 144: MEA Market Value (US$ Million) by Country, 2022 to 2032

Figure 145: MEA Market Value (US$ Million) Analysis by Country, 2017 to 2032

Figure 146: MEA Market Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 147: MEA Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 148: MEA Market Value (US$ Million) Analysis by Test Type, 2017 to 2032

Figure 149: MEA Market Value Share (%) and BPS Analysis by Test Type, 2022 to 2032

Figure 150: MEA Market Y-o-Y Growth (%) Projections by Test Type, 2022 to 2032

Figure 151: MEA Market Value (US$ Million) Analysis by Test Method, 2017 to 2032

Figure 152: MEA Market Value Share (%) and BPS Analysis by Test Method, 2022 to 2032

Figure 153: MEA Market Y-o-Y Growth (%) Projections by Test Method, 2022 to 2032

Figure 154: MEA Market Value (US$ Million) Analysis by End-user, 2017 to 2032

Figure 155: MEA Market Value Share (%) and BPS Analysis by End-user, 2022 to 2032

Figure 156: MEA Market Y-o-Y Growth (%) Projections by End-user, 2022 to 2032

Figure 157: MEA Market Attractiveness by Test Type, 2022 to 2032

Figure 158: MEA Market Attractiveness by Test Method, 2022 to 2032

Figure 159: MEA Market Attractiveness by End-user, 2022 to 2032

Figure 160: MEA Market Attractiveness by Country, 2022 to 2032